8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K

                                 CURRENT REPORT


                       Pursuant to Section 13 or 15(d) of
                      the Securities and Exchange Act 1934



Date of Report:     October 22, 2004

                            INTEGRAMED AMERICA, INC.
- --------------------------------------------------------------------------------
               (Exact name of registrant as specified in charter)


                                    Delaware
- --------------------------------------------------------------------------------
                 (State of other jurisdiction of incorporation)


                 0-20260                               6-1150326
- --------------------------------------------------------------------------------
        (Commission File Numbers)          (IRS Employer Identification No.)


  Two Manhattanville Road, Purchase, NY                 10577
- --------------------------------------------------------------------------------
 (Address of principal executive offices)             (Zip Code)


Registrant's telephone no. including area code: (914) 253-8000
                                                --------------


Registrant's former name: IVF America, Inc.
                          -----------------





ITEM 7.  Financial Statements, Pro Forma Financial Information and Exhibits

         (c)  Exhibits

              Exhibit No.   Description of Exhibit
              -----------   ----------------------
              99.67        Registrant's Press Release dated October 21, 2004

ITEM 9.  Regulation FD disclosure

         Registrant's Press Release dated October 21, 2004 attached as Exhibit
99.67 hereto is furnished pursuant to Regulation FD; it is not filed.






                                                          SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                           INTEGRAMED AMERICA, INC.
                                           (Registrant)




Date:   October 22, 2004               By: /s/John W. Hlywak, Jr.
                                          -------------------------------------
                                           John W. Hlywak, Jr.
                                           Sr. Vice President and
                                           Chief Financial Officer
                                           (Principal Financial and
                                           Accounting Officer)

EX-99.67

- -


John W. Hlywak, Jr. (Investors)            Jay Higham (Media/Physicians)
Senior Vice President and                  President and
Chief Financial Officer                    Chief Operating Officer
IntegraMed America, Inc.                   IntegraMed America, Inc.
(914) 251-4143                             (914) 251-4127
email:  jhlywak@integramed.com             email:  jhigham@integramed.com
        ----------------------                     ----------------------
Web Address:  http://www.integramed.com
              -------------------------

         INTEGRAMED AMERICA TO HOLD THIRD QUARTER 2004 FINANCIAL RESULTS
                        CONFERENCE CALL OCTOBER 28, 2004

Purchase, NY, October 21, 2004 - IntegraMed America, Inc. (Nasdaq: INMD) today
announced that the Company will release third quarter 2004 financial results on
Wednesday, October 27, 2004, after the close of the financial markets. Gerardo
Canet, Chairman and Chief Executive Officer, Jay Higham, President and Chief
Operating Officer and John Hlywak, Senior Vice President and Chief Financial
Officer, will host an investment-community conference call beginning Thursday,
October 28, 2004, at 10:00 a.m. Eastern Time to discuss those results and to
answer questions.

To participate in the live call via telephone, please call (800) 374-0146
(domestic) or (706) 634-1307 (international). A telephone replay will be
available 12:00 p.m. Eastern Time, October 28 through November 4, 2004 by
dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering
reservation number 1730397.

Individuals interested in listening to the conference call via the Internet may
do so by visiting the Company's web site at www.integramed.com. A replay will be
available on the web site for 14 days.

IntegraMed America, based in Purchase, N.Y., is focused on the $2 billion
infertility industry, and offers products and services to patients and
providers. Specifically, the Company provides Business Services to a network of
Fertility Centers; distributes pharmaceutical products and financing programs
directly to patients; and operates www.integramed.com, an award-winning
infertility Web site.

Statements contained in this press release that are not based on historical
fact, including statements concerning future results, performance, expectations
and expansion of IntegraMed America are forward-looking statements that may
involve a number of risks and uncertainties. Actual results may differ
materially from the statements made as a result of various factors, including,
but not limited to, the risks associated with the Company's ability to finance
future growth; the loss of significant business service contract(s);
profitability at Reproductive Science Centers serviced by IntegraMed America;
changes in insurance coverage, government laws and regulations regarding health
care or managed care contracting; and other risks, including those identified in
the Company's most recent Form 10-K and in other documents filed by the Company
with the U.S. Securities and Exchange Commission.